BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 11304876)

  • 1. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials.
    Gitlin N; Korner P; Yang HM
    Menopause; 1999; 6(3):216-24. PubMed ID: 10486791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and antiandrogens.
    Schneider HP
    Ann N Y Acad Sci; 2003 Nov; 997():292-306. PubMed ID: 14644837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of menopausal androgen supplementation.
    Slayden SM
    Semin Reprod Endocrinol; 1998; 16(2):145-52. PubMed ID: 9711680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
    Spetz AC; Fredriksson MG; Lidfeldt J; Samsioe GN
    Menopause; 2009; 16(1):149-55. PubMed ID: 18779755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and the breast.
    Shufelt CL; Braunstein GD
    Menopause Int; 2008 Sep; 14(3):117-22. PubMed ID: 18714077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and adverse effects of androgens: how to counsel patients.
    Basaria S; Dobs AS
    Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S25-32. PubMed ID: 15065635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-androgen for hormone replacement. A review.
    Rosenberg MJ; King TD; Timmons MC
    J Reprod Med; 1997 Jul; 42(7):394-404. PubMed ID: 9252929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
    Dobs AS; Nguyen T; Pace C; Roberts CP
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen/androgen therapy on bone mineral density parameters.
    Notelovitz M
    J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone effects on the breast: implications for testosterone therapy for women.
    Somboonporn W; Davis SR;
    Endocr Rev; 2004 Jun; 25(3):374-88. PubMed ID: 15180949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens and breast cancer risk.
    Kenemans P; van der Mooren MJ
    Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():46-9. PubMed ID: 22394304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.